Cardiol Therapeutics Announces Over $7M In Proceeds From Warrant Exercises, Extending Cash Runway Into H1 2028; Issues Acceleration Notice On 425,000 Remaining Warrants, Expiring October 16
Share
Why It Matters
Cardiol Therapeutics got over $7 million from people exercising stock warrants. This money helps the company pay bills and keep going longer.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.